The leading team of biotech experts

 

Biomedican aims to remain at the forefront of biotechnology by employing a diverse team of highly qualified scientists from around the world with expertise in biosynthesis, molecular biology, genetics, genomics, and engineering. Our scientists have over 50 years of combined research experience and have established a cutting-edge research laboratory in California.

Science team

Max-Mikheev

MAX MIKHEEV, Ph.D.

Chief Executive / Science Officer 

Difeng-Gao

DIFENG GAO, Ph.D.

Lead Scientist

circle-cropped

EVGENIYA YUZBASHEVA, Ph.D.

Senior Scientist

Andrey Kononenko - Biomedican

ANDREY ROMANENKO, Ph.D.

Lead Engineer

BIO

During his 22 years of genomics experience, Max has been a co-inventor of multiple patent applications related to genetic modifications. He co-founded the first Hadoop-based big data genomic analysis platform – BioDatomics and a genomic pathways software startup – BioSoft RU.

BIO

Difeng is an accomplished scientist with 11 years of molecular biology experience, including 6 years of experience with Yarrowia Lipolytica, CRISPR, and simultaneous integration of multiple genes.

BIO

Evgeniya is a scientist with 20 years of experience in molecular biology, including 16 years of experience working with YL. Her research areas include optimizing internal energy pathways and fatty acid production improvements.

BIO

Andrey is a mechanical and electrical engineer with 20 years experience in development and building customized equipment

Join our team

 

Join our team of international biotechnology experts, scientists, and engineers to revolutionize the current cannabinoid and terpene markets. Become a part of the rapidly growing therapeutic cannabinoid revolution – help our company grow into the leading producer of biosynthetic cannabinoids and terpenes.

 

Open positions: 

 

Management team

Max-Mikheev

MAX MIKHEEV

Chief Executive/Science Officer

Dennis O'Neill, President, Biomedican

DENNIS O’NEILL

President

Board of Directors

Max-Mikheev

MAX MIKHEEV

Chief Executive/Science Officer

Biomedican

Biomedican Reggie Gaudino Ph.D.

REGGIE GAUDINO, Ph.D.

VP Research & Development

Front Range Biosciences

Dennis O'Neill, President, Biomedican

DENNIS O’NEILL

President

Biomedican

Hamish-Sutherland

HAMISH SUTHERLAND

President and co-CEO

White Sheep Corp

BIO

During his 22 years of genomics experience, Max has been a co-inventor of multiple patent applications related to genetic modifications. He co-founded the first Hadoop-based big data genomic analysis platform – BioDatomics and a genomic pathways software startup – BioSoft RU.

BIO

Dr. Gaudino oversees the cannabis genetics and scientific research division for Front Range Biosciences. Formerly the President at Steep Hill, the acquisition of Reggie and his team has significantly advanced FRB’s breeding program, resulting in additional unique and advantaged cannabis and hemp varieties.

As an internationally recognized leader in the field of cannabis genetics, Dr. Gaudino has served as a patent agent at Sequenom, Inc., managed IP-based acquisitions for the Vortice Research Group, worked at four law firms focused on biotechnology, and an advisor to multiple portfolio investment companies.

Dr. Gaudino received his B.S. in Molecular Biology and Ph.D. in Molecular Genetics from the State University of New York at Buffalo and conducted four years of post-doctoral research at Washington University in St. Louis.

BIO

Dennis O’Neill has over 30 years of experience as an Investment Banker. He helped start two of the largest regional investment banks in Chicago then went on to Managing Director for Softbank Investments/ E2Capital office in Chicago and raised over 2 billion dollars in capital for early-stage companies to date.

Mr. O’Neill has a significant amount of experience and success in Sales, Marketing, Financial Media, Business Development, and Institutional Capital Raises. He is an expert and thought leader on Venture Capital, Private Equity, Blockchain, and smallcap stocks and has spoken at over 75 conferences around the world.

BIO

Hamish is one of a rare few who has actual hands-on experience in building a successful cannabis company, passing more than 50 surprise inspections that were led by the excellent specialists at Health Canada. As the founding COO for Bedrocan Canada, Hamish delivered over $600 million in returns for shareholders.

Hamish also has built start-ups on three continents and consulted to established brands including Upper Canada Brewing Company, Bid.Com, Coopers & Lybrand, and ResearchNow.

Hamish is a Professional Engineer (Engineering Physics) in Ontario, earned his MBA from Schulich, and is the active Chair of the Little Geeks Foundation. He loves basketball, sailing, and helping everyone achieve their potential.